Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study - Wikidata - wikimedia - TriplyDB

Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study

Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study

http://www.wikidata.org/entity/Q35843119

about

Antibiotic therapy for Shigella dysentery Antibiotic therapy for Shigella dysentery Antibiotic therapy for Shigella dysentery Diarrhoea in adults (acute)New Developments in Traveler's Diarrhea Infectious disease: diarrhea.Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species Review article: travellers' diarrhoea.Diarrhoea in adults (acute).Antibiotic treatment for travellers' diarrhoea.Empirical antimicrobial therapy for traveler's diarrhea.Travelers' diarrhea: antimicrobial therapy and chemoprevention.Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.Prevention and self-treatment of traveler's diarrhea.Expert review of the evidence base for self-therapy of travelers' diarrhea.Current and future developments in travelers' diarrhea therapy.Optimal dosing of trimethoprim-sulfamethoxazole when used with loperamide to treat traveler's diarrhea.Systematic review: the epidemiology and clinical features of travellers' diarrhoea.The practice of travel medicine: guidelines by the Infectious Diseases Society of America.Update on Traveler's Diarrhea.Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travelers to India in comparison with other geographical areas.Antibiotic Therapy for Acute Watery Diarrhea and Dysentery.Travellers' diarrhea in children Travellers' diarrhoea: slow but steady progress.Travelers' diarrhea: modern concepts and new developments.Norfloxacin and Salmonella excretion in acute gastroenteritis--a 6-month follow-up study.Application of Bromophenol Blue and Bromocresol Purple for the Extractive-Spectrophotometric Determination of Ofloxacin

P2860

Q24236428-9C488B39-CAE4-4E8E-9A00-509A73206045 Q24239993-37A23B98-C199-4E17-AB6A-552B5BB2270B Q24240889-80B36901-652B-47EE-8321-EF5B4CB11C72 Q24605037-141A490B-D9EC-4153-97CB-C6E0B92E1BF7 Q28387036-A496F9ED-EB57-4F7C-86F7-F89339B2D913 Q33727757-219BFF2F-348E-4D55-8324-D262D571F7DE Q33769570-639FD90F-23AC-424B-AA4F-60682E9E22CC Q33778796-6EF285ED-9438-4011-A037-5CD845A28386 Q33947397-C5533CB5-1AD1-4D05-9539-BFBC15096AEF Q33978592-C4947DC1-B0C3-4686-92C1-FCFA7EDEDF21 Q34069481-3CB5BCA7-2B81-449A-8639-B3FD1346B411 Q34464671-B6DA501E-EE28-46BB-9B28-2CF4A803AF82 Q34519193-679417EF-17FD-4B01-863F-0CEAD716A289 Q34974972-4910A716-5BD1-4297-AC07-4C1EA7A648AF Q34987675-B388EF60-9DE3-42E3-AD1C-C1673E1E892C Q36505498-E3144507-FF9D-4D56-8E65-5E2573AD4E1F Q36758420-92070E82-DC17-487F-ADD7-8CA151BB5CCA Q37458962-243FC4AB-4035-4D9D-8BD8-8458D834AB37 Q39067681-4E904718-4439-4701-9390-71EA51FEA7DA Q39410276-E3A19F43-8738-4024-BEBA-762B4DF2D9C5 Q39474249-F5D1A443-ECAC-442A-9B55-0D2194AAB830 Q40060459-324A4706-F079-49B7-A86E-BF4EDD46515D Q41934450-C29632BF-A94D-4F55-A6EC-24EC88045D79 Q43240701-4C3785A5-1CC5-45A4-9E64-15E2F06A06DC Q46901378-A3FD5AAE-80D6-4388-B7CE-7D278A63A06F Q50140918-479BD717-DCE1-45A6-B4E8-0B84C3F6195B Q58150477-67305D25-9302-4CB5-BFA0-26C5A2A37D4D

P2860

Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study

http://www.wikidata.org/entity/Q35843119

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年学术文章

@wuu

1992年学术文章

@zh-cn

1992年学术文章

@zh-hans

1992年学术文章

@zh-my

1992年学术文章

@zh-sg

1992年學術文章

@yue

1992年學術文章

@zh

1992年學術文章

@zh-hant

name

Five versus three days of oflo ...... ea: a placebo-controlled study

@ast

Five versus three days of oflo ...... ea: a placebo-controlled study

@en

type

label

Five versus three days of oflo ...... ea: a placebo-controlled study

@ast

Five versus three days of oflo ...... ea: a placebo-controlled study

@en

prefLabel

Five versus three days of oflo ...... ea: a placebo-controlled study

@ast

Five versus three days of oflo ...... ea: a placebo-controlled study

@en

P1433

Q35843119-F093C641-7DE5-4E64-A734-A07E55D28D67

P1476

Q35843119-83C04172-1F77-491F-881A-994822B4555B

P2093

Q35843119-1ECA43BA-3313-47C8-B5FB-BC33DE6C6331

Q35843119-3403B747-D35E-4781-88B5-09B5AD02F8AD

Q35843119-8737E917-17FE-4A97-B470-CFE9ABB59A1D

Q35843119-DC4B8251-979E-44E1-B794-BDDC3DCD729A

P2860

Q35843119-0560A2DD-FE53-4733-971C-569C3163CB65

Q35843119-0D4BC899-A4FF-4D2D-A67A-6CE7D7E21FBF

Q35843119-2F5EDC11-2D04-4B9D-A03F-C6D2A35487E6

Q35843119-3ADB12B9-D3F4-4007-A085-757BA88C2EEB

Q35843119-4BC09253-F1B8-47E8-8E74-F6CF089076D2

Q35843119-5591601C-0EB6-48D4-A59B-1571C8B3561B

Q35843119-78C9F6F0-9BEE-4B55-85B3-D58718FDF82F

Q35843119-7A0EE987-10AB-4A3D-9571-1C85892C4076

Q35843119-82B9F6BF-4D80-4858-BA22-086537DC6E62

Q35843119-839FA20F-550E-4711-ABBA-D88885967C26

P304

Q35843119-86AA3ADA-33D4-4236-BEF6-9A26DEAB69CB

P31

Q35843119-7D1DCDEC-DAF3-4D79-8A15-5F5300B588E8

P356

Q35843119-B4AFD602-A152-42D3-B275-B39399FF6360

P407

Q35843119-BDF2CFFA-ADFA-4FCF-9226-784FC9DB8978

P433

Q35843119-556BC64C-AB72-4BAA-9ACB-5AB41C0A066E

P478

Q35843119-868101CF-24D5-4630-A074-D03394357868

P577

Q35843119-42D3C00F-2CB6-4E44-A380-D3A1C17B1D41

P698

Q35843119-C0E48E6A-0839-4767-8B4F-FDAD327464BB

P921

Q35843119-45E70F1E-9283-4B56-A884-0E90B6A5CB5B

Q35843119-5A665653-86C9-4AC7-98AB-43F0120794DA

P932

Q35843119-0DC12C77-57D9-402F-AFC3-31D3DEA560A0

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Five versus three days of oflo ...... ea: a placebo-controlled study

@en

P2093

C D Ericsson

http://www.w3.org/2001/XMLSchema#string

H L DuPont

http://www.w3.org/2001/XMLSchema#string

J J Mathewson

http://www.w3.org/2001/XMLSchema#string

M W DuPont

http://www.w3.org/2001/XMLSchema#string

P2860

Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers.

Furazolidone versus ampicillin in the treatment of traveler's diarrhea

Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.

Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone.

Treatment of traveler's diarrhea with sulfamethoxazole and trimethoprim and loperamide.

Test-of-cure stool cultures for traveler's diarrhea.

Comparative pharmacokinetics of ofloxacin and ciprofloxacin.

Effect of oral ofloxacin on fecal bacteria in human volunteers.

Efficacy of trimethoprim-sulfamethoxazole in treatment of acute diarrhea in a Mexican pediatric population.

Fecal leukocytes in diarrheal illness.

P304

87-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.36.1.87

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

1992-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1590705

http://www.w3.org/2001/XMLSchema#string

P921

Afọ ọsịsa

P932

189232

http://www.w3.org/2001/XMLSchema#string